Temozolomide monotherapy versus combination therapies in melanoma: a meta-analysis of efficacy and safety. Chen L, Cai B, Ni X, Lin Q, et al. Melanoma Res 2025 Jan 28. doi: 10.1097/CMR.0000000000001021.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Chen L, Cai B, Ni X, Lin Q, et al. Temozolomide monotherapy versus combination therapies in melanoma: a meta-analysis of efficacy and safety. Melanoma Res 2025 Jan 28. doi: 10.1097/CMR.0000000000001021.
PMID: 39874124